What amount sold does Veana Therapeutics, Inc. report in Form D filings?

The latest linked filings report $1.4M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Veana Therapeutics, Inc.'s most recent SEC filing?

Veana Therapeutics, Inc.'s most recent Form D filing was on 2020-11-13.

How many investors does Veana Therapeutics, Inc. have?

The most recent Form D filing lists 4 investor(s).

What type of securities does Veana Therapeutics, Inc. offer?

Veana Therapeutics, Inc.'s SEC Form D filings indicate equity offerings.

Veana Therapeutics, Inc.

CIK: 0001741217·Pharmaceuticals·PORTLAND, OR·Corporation·Founded 2015

Reported Sold

$1,372,998

Total Filings

Identified Offerings

Last Filed

Nov 13, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Nov 13, 2020Form D — New notice

Reported sold: $830,998 · Target: $1,265,000

Section 4(a)(2)·4 investors·Rule 506(b)

May 21, 2018Form D — New notice

Reported sold: $542,000 · Target: $2,000,000

Rule 506(b)·9 investors

Fundraising Profile

Exemptions

Section 4(a)(2)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$1,372,998

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Rebecca Akporiaye

Related Person

Appears on 2 filings

Emmanuel Akporiaye

Related Person

Appears on 2 filings

F Andrew Ray

Related Person

Appears on 1 filing

Denis R Burger

Related Person

Appears on 1 filing

Andrew D Thaler

Related Person

Appears on 1 filing

Thomas E McChesney

Related Person

Appears on 1 filing

BRUCE RAMSEYER

Related Person

Appears on 1 filing

ANDREW RAY

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 13, 2020	New	$1,265,000	$830,998	4
May 21, 2018	New	$2,000,000	$542,000	9

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026